ŗ£½ĒĘƽā°ę

³¾°Õ±š³§øéā„¢1

cGMP, feeder-free maintenance medium for human ES and iPS cells

Need a high-quality cell source? Choose from our hiPSC healthy control lines, manufactured with mTeSRā„¢ Plus.

³¾°Õ±š³§øéā„¢1

cGMP, feeder-free maintenance medium for human ES and iPS cells

Catalog #
(Select a product)
cGMP, feeder-free maintenance medium for human ES and iPS cells
Request Pricing Request Pricing

What's Included

  • ³¾°Õ±š³§øéā„¢1 Complete Kit (Catalog #85850)
    • ³¾°Õ±š³§øéā„¢1 Basal Medium, 400 mL
    • ³¾°Õ±š³§øéā„¢1 5X Supplement, 100 mL
  • ³¾°Õ±š³§øéā„¢1 Complete Kit, 1 L (Catalog #85857)
    • ³¾°Õ±š³§øéā„¢1 Basal Medium, 800 mL
    • ³¾°Õ±š³§øéā„¢1 5X Supplement, 100 mL, 2 Bottles

What Our Scientist Says

It makes me proud knowing that my work is critical to keeping thousands of hPSC lines reliably healthy and consistent around the world.

Arwen HunterAssociate Director, Stem Cell Biology
Arwen Hunter, Associate Director, Stem Cell Biology

Overview

Use this specialized, feeder-free culture medium to achieve more consistent human pluripotent stem cell (hPSC) cultures with homogenous, undifferentiated phenotypes.

Manufactured under relevant cGMPs, ³¾°Õ±š³§øéā„¢1 ensures the highest quality and consistency for reproducible results in your fundamental research, as well as for cell therapy and investigational new drug research applications. This serum-free, complete cell culture medium is made with pre-screened raw materials to ensure batch-to-batch consistency and robust performance in feeder-free hPSC culture.

Use established protocols for applications ranging from derivation to differentiation with this most widely published feeder-free hPSC culture medium, which has been used by leading pluripotent stem cell researchers to successfully maintain thousands of hPSC lines in over 50 countries. For enhanced cell performance and versatile maintenance, you may also be interested in mTeSRā„¢ Plus medium, which is also manufactured under relevant cGMPs and features stabilized components and enhanced buffering.

To request a Letter of Authorization (LOA) for the FDA Master File for ³¾°Õ±š³§øéā„¢1, click here.
Subtype
Specialized Media
Cell Type
Pluripotent Stem Cells
Species
Human
Application
Cell Culture, Expansion, Maintenance
Brand
TeSR
Area of Interest
Stem Cell Biology
Formulation Category
Serum-Free

Data Figures

Figure 1. Normal hES and hiPS Cell Morphology is Observed in cGMP ³¾°Õ±š³§øéā„¢1 Cultures

Undifferentiated (A) H1 human embryonic stem (hES) and (B) WLS-1C human induced pluripotent stem (hiPS) cells cultured on CorningĀ® MatrigelĀ® Matrix in cGMP ³¾°Õ±š³§øéā„¢1 retain the prominent nucleoli and high nuclear-to-cytoplasmic ratio characteristic of this cell type after 10 passages. Densely packed cells and multi-layering are prominent when cells are ready to be passaged.

Figure 2. High Expansion Rates are Observed in cGMP ³¾°Õ±š³§øéā„¢1 Cultures

Graph shows the average fold expansion per passage +/- SEM obtained for hES (H1 and H9) and hiPS (WLS-1C) cells cultured in cGMP mTeSRĀ­ā„¢1 (red) or non-cGMP ³¾°Õ±š³§øéā„¢1 (gray) on CorningĀ® MatrigelĀ® Matrix over 10 passages. Expansion was determined by enumerating the cell aggregates obtained at harvest and dividing by the number of cell aggregates seeded. Note that this data is representative of cultures passaged after 6-7 days in culture, lower expansion should be expected if using shorter culture times.

Figure 3. Cells Cultured in cGMP ³¾°Õ±š³§øéā„¢1 Medium Express Undifferentiated Cell Markers

Histogram analysis for hES (H1 and H9) and hiPS (WLS-1C) cells characterized using FACS for undifferentiated cell markers, OCT4 (OCT3) (Catalog #60093) and TRA-1-60 (Catalog #60064), after 8 - 10 passages in cGMP ³¾°Õ±š³§øéā„¢1 (filled = sample, blank = isotype control).

Figure 4. hPSCs Maintained in cGMP ³¾°Õ±š³§øéā„¢1 Display a Normal Karyotype

Karyograms of (A) H1 hES and (B) WLS-1C hiPS cells cultured in cGMP ³¾°Õ±š³§øéā„¢1 for 11 passages shows that a normal karyotype is retained.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
85857, 85850
Lot #
All
Language
English
Document Type
Product Name
Catalog #
85850, 85857
Lot #
All
Language
English
Document Type
Product Name
Catalog #
85857, 85850
Lot #
All
Language
English
Document Type
Product Name
Catalog #
85857, 85850
Lot #
All
Language
English
Document Type
Product Name
Catalog #
85857, 85850
Lot #
All
Language
English
The Certificate of Analysis for this product has been updated for newly released materials. To access respective CoAs please use this tool.

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Educational Materials (41)

Brochure
Brochure
Brochure
Brochure
Brochure
Brochure

Publications (1871)

Modular RNA interactions shape FXR1 condensates involved in mRNA localization and translation J. Yang et al. Nature Communications 2025 Sep

Abstract

Biomolecular condensates are found throughout a diversity of eukaryotic cell types and cellular compartments, playing roles in various cellular functions. A given protein generally forms functionally and compositionally heterogeneous condensates, but the underlying regulatory mechanisms are unknown. Here, we found that different RNA motifs modulate the formation of heterogeneous mRNA-protein condensates via riboregulation. Fragile X-related 1 (FXR1), an RNA-binding protein interacting with nuclear pores, assembles distinct localized subcellular mRNP condensates linked to cytosolic accumulation of G-quadruplex-containing pluripotent mRNAs and the localized translation of nucleoporin mRNAs at nuclear pores. The diverse locations of FXR1 condensates depend on the unique RNA-protein interaction modules of its two RNA binding domains, and the opposing effects of different RNA motifs on the affinity of FXR1 for nuclear pores. Notably, reduced FXR1 levels and impaired nuclear pore function lead to the nuclear accumulation of transcribed RNAs, facilitating fate transition in human embryonic stem cells. Preventing this decline would result in impaired hESC differentiation. Subject terms: RNA metabolism, Embryonic stem cells, RNA, RNA transport
Metal-organic polyhedra maintain the self-renewal of embryonic stem cells R. Wang et al. Nature Communications 2025 Sep

Abstract

Embryonic stem cells (ESC) are pluripotent, with the potential to differentiate into multiple cell types, making them a valuable tool for regenerative medicine and disease therapy. However, common culture methods face challenges, including strict operating procedures and high costs. Currently, Leukemia inhibitory factor (LIF), an indispensable bioactive protein for ESC culture, is typically applied to maintain self-renewal and pluripotency, but its instability and high cost limit its effectiveness in stable culture conditions. Hence, we have developed an innovative strategy using a soluble nanomaterial, metal-organic polyhedra (MOPs), to effectively maintain the self-renewal and pluripotency of ESC. The selected amino-modified vanadium-based MOP not only exhibits excellent biocompatibility and high stability but also possesses similar or even superior biological functions compared to commercial LIF. Due to the precise structure of MOPs, the active site responsible for maintaining ESC pluripotency has been identified and regulated at the molecular level. The new ESC culture method significantly reduces costs, simplifies preparation, and enhances the practicality of biopharmaceutical preparation and storage. This represents the first case of using MOPs to maintain self-renewal of ECS, opening an avenue for introducing advanced materials into the development of innovative ESC culture methods. Subject terms: Biomaterials - cells, Chemical biology
Polygenic risk score of Alzheimer's disease is associated with cognitive trajectories and phenotypes of cerebral organoids M. Y. Chun et al. Alzheimer's & Dementia 2025 Sep

Abstract

INTRODUCTIONPolygenic risk score (PRS) identifies individuals at high genetic risk for Alzheimer's disease (AD), but its utility in predicting cognitive trajectories and AD pathologies remains unclear. We optimized PRS (optPRS) for AD, investigated its association with cognitive trajectories and AD phenotypes of cerebral organoids.METHODSUsing genome‐wide association study (GWAS) summary statistics from a European population, we developed optPRS to predict AD in Korean individuals (nĀ =Ā 1634). We analyzed the association between optPRS and cognitive trajectories (nĀ =Ā 771). We generated induced pluripotent stem cell–derived cerebral organoids from patients with high (nĀ =Ā 3) and low (nĀ =Ā 4) optPRS to evaluate amyloid beta (Aβ) and phosphorylated tau (p‐tau) levels.RESULTSOptPRS predicted AD dementia and Aβ positivity, independent of apolipoprotein E (APOE). Higher optPRSs correlated with rapid cognitive decline. Cerebral organoids from the high optPRS group exhibited increased Aβ insolubility and p‐tau levels.CONCLUSIONOptPRS predicted cognitive decline and AD phenotypes of cerebral organoids, supporting its use in risk assessments and drug‐screening platform.Highlights Optimized polygenic risk scores (optPRSs) improve the prediction of Alzheimer's disease (AD) dementia and amyloid beta positivity (Aβ+).High optPRS is associated with faster cognitive decline, particularly in Aβ+.Induced pluripotent stem cell (iPSC)–derived cerebral organoids from high optPRSs show high Aβ insolubility and phosphorylated tau (p‐tau).PRS genetic risk stratification provides insight into AD progression and pathology.
Need a high-quality cell source? Choose from our hiPSC healthy control lines, manufactured with mTeSRā„¢ Plus.